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Long-term Luminal Renarrowing After Successful Elective Coronary
Angioplasty of Total Occlusions
A Quantitative Angiographic Analysis
Andonis G. Violaris, Rein Melkert, and Patrick W. Serruys
Abstract
Background The long-term angiographic outcome after successful dilatation of coronary occlusions remains unclear. The
objective of this study was to examine long-term restenosis after successful balloon dilatation of coronary occlusions at a
predetermined time interval with quantitative angiography and compare this with a control population of stenoses.
Methods and Results The study population comprised 2950 patients (3583 lesions) prospectively enrolled in and
successfully completing four major restenosis trials (86% quantitative angiographic follow-up). Cineangiographic films were
processed and analyzed at a central core laboratory with the use of an automated interpolated edge detection technique.
The study population comprised 266 occlusions (7%) defined as total when there was absent anterograde filling beyond the
lesion (109 lesions) and functional (157 lesions) when faint, late anterograde opacification of the distal segment was seen in
the absence of a discernible luminal continuity; 3317 lesions were defined as stenoses (93%). Restenosis was significantly
higher after successful dilatation of occlusions than of stenoses. With the categorical (>50% diameter stenosis at follow-up)
approach, the restenosis rate was 44.7% in occlusions compared with 34.0% in stenoses (P<.001; relative risk, 1.575; CI,
1.224 to 2.027). Similarly, the absolute loss (defined as the change in minimal lumen diameter between post coronary
angioplasty and follow-up; in millimeters, mean±SD) (0.43±0.68) in occlusions was significantly higher than in stenoses
(0.31±0.51, P<.001), as was the relative loss, defined as the change in minimal lumen diameter between postangioplasty
and follow-up, adjusted for the vessel size (0.17±0.28 versus 0.12±0.20, P<.001). The higher restenosis rate in the
occlusions group was due predominantly to an increased number of occlusions at follow-up angiography in this group
(19.2% compared with 5.0% for stenoses, P<.001). Within the occlusions group, there were no significant differences in
long-term outcome between total and functional occlusions (restenosis rate, 45.0% versus 44.6%; reocclusion rate, 23.9%
versus 15.9%; absolute loss, 0.53±0.69 versus 0.36±0.67; relative loss, 0.21±0.28 versus 0.15±0.28; P=NS).
Conclusions These results indicate that successfully dilated coronary occlusions, both total and functional, have a higher
rate of angiographic restenosis at 6 months than stenoses. This is due chiefly to a higher rate of occlusion at follow-up
angiography in this group of lesions. Measures aimed at reducing restenosis after successful dilatation of coronary
occlusion should be focused in this direction.
After the introduction of coronary angioplasty by Grüntzig et al in 1979,  the indication for its use were at first tentatively and
subsequently more strikingly expanded to include patients with total occlusions.  Although a number of factors are
known to influence the acute success rate,  relatively little is known regarding long-term luminal renarrowing after
successful dilatation of total occlusions. A number of studies have investigated this, but uncertainty continues with
restenosis rates in the literature varying from 20% to 65%.  This variation has three primary sources.
First, most studies have been retrospective analyses that use small patient numbers and no control group.
Second, the angiographic follow-up rates have been low and performed for the recurrence of symptoms rather than at a
predetermined time interval, thus introducing important selection bias.  Finally, some have used visual assessment to
estimate angiographic severity, which is subject to wide interobserver and intraobserver variability.  This study attempted to
overcome these limitations by using a validated automated edge detection technique to evaluate restenosis prospectively in
a large series of patients undergoing successful balloon angioplasty and routine follow-up angiographic assessment at a
predetermined time interval. Furthermore, a control cohort of patients with stenoses was used to directly compare the long-
term results.
Methods
Patients
The study population comprised 3582 patients with significant primary stenoses in native coronary arteries who were
prospectively enrolled in four major restenosis trials  and who underwent successful coronary angioplasty
(postprocedural stenosis <50%). These trials demonstrated that active therapy had no effect on restenosis or clinical
outcome in the first 6 months after balloon angioplasty, so for the purposes of this study, the data for the active and placebo
groups were pooled. Men or women were eligible for study entry if they were symptomatic or asymptomatic with stable or
unstable angina pectoris and proven angiographically significant narrowing in one or more major coronary arteries.
Informed consent was obtained in all cases before the coronary angioplasty procedure. Patients with evolving myocardial
infarction and significant left main disease were excluded from the study.
Angioplasty Procedure and Follow-up Angiography
Coronary angioplasty was performed with a steerable, moveable guide wire system by the femoral route. Standard balloon
catheters were used. The choice of balloon type and brand, inflation duration, and inflation pressure was left to the
discretion of the operator. Patients were followed up for 6 months; then a follow-up study was performed. If symptoms
recurred within 6 months, coronary angiography was performed earlier. If no definite restenosis was present and the follow-
up time was less than 4 months, the patient was asked to undergo further coronary arteriography at 6 months.
Quantitative Angiography
In total, three coronary angiograms were obtained for each patient—before and after percutaneous transluminal coronary
angioplasty (PTCA) and at angiographic follow-up. To standardize the method of data acquisition and to ensure exact
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reproducibility of the angiographic studies, measures were taken as previously described, and all angiograms were
processed in a central angiographic core laboratory.  The angiograms were recorded in such a manner that they were
suitable for quantitative analysis by the computer-assisted CORONARY ANGIOGRAPHY ANALYSIS SYSTEM, which was described and
validated earlier.  Because the computer algorithm cannot measure total occlusions, a value of 0 mm was substituted for
the minimal lumen diameter and a value of 100% for the pre-PTCA percent diameter stenosis. In these cases, the post-
PTCA reference diameter was substituted for vessel size.
Definitions
Total Occlusion
As in previous studies, total occlusions were divided into absolute occlusions (Thrombolysis in Myocardial Infarction [TIMI]
flow grade 0) where no anterograde filling beyond the lesion was visible and functional occlusions (TIMI grade 1) where
faint, late anterograde opacification of the distal segment was present in the absence of a discernible luminal continuity.
Occlusion at Follow-up Angiography
Occlusion at follow-up angiography was defined as the presence of an absolute or functional occlusion at the previously
dilated angioplasty site on angiographic follow-up.
Angiographic Parameters Assessed
Vessel size refers to the reference diameter of the relevant coronary segment and is represented by the interpolated
reference diameter pre-PTCA because this is the closest and most objective approximation of the disease-free vessel wall.
Minimum luminal diameter (MLD) is the point of maximal luminal narrowing in the analyzed segment.
Many criteria have been proposed for the assessment of restenosis.  For the purposes of this study, two approaches
were used: the categorical approach with the traditional cutoff point of >50% diameter stenosis at follow-up and a
continuous approach that used absolute and relative loss, which reflect the behavior of the lesion during and after
angioplasty and may be more representative of the pathological process involved during follow-up.
Absolute gain and absolute loss represent the improvement in MLD achieved at intervention and the absolute change
during follow-up respectively, measured in millimeters. Absolute gain is post-PTCA MLD minus pre-PTCA MLD. Absolute
loss is post-PTCA MLD minus MLD at follow-up.
Relative gain and relative loss depict the improvement in MLD achieved at intervention and the change during follow-up
respectively, normalized for vessel size. Relative gain is (post-PTCA MLD minus pre-PTCA MLD) divided by vessel size.
Relative loss is (post-PTCA MLD minus MLD at follow-up) divided by vessel size.
The absolute net gain is the MLD at follow-up minus pre-PTCA MLD. The net gain index is the net gain normalized for the
vessel size. The net gain index is (MLD at follow-up minus pre-PTCA MLD) divided by vessel size.
The loss index is the relation of late loss to acute gain: loss index is (MLD at follow-up minus post-PTCA MLD) divided by
(post-PTCA MLD minus pre-PTCA MLD).
Statistical Analysis
Data were analyzed with the SAS statistical software package. Categorical variables are presented as absolute numbers (%).
Continuous variables are expressed as mean value±SD. Differences between groups were evaluated with adjusted χ  tests
for categorical variables and Student’s t tests for continuous variables. The contributions of clinical, angiographic, and
procedural variables to the categorical outcome parameters were evaluated with logistic regression analysis. For the
continuous outcome parameter (absolute loss), multiple linear regression analysis was used. Categorical variables were
dichotomized and entered into the analysis as indicator variables with values of 0 and 1. Selection of variables was
achieved in a stepwise fashion. The adjusted R  was used as the criterion for model selection. Probability values <.05 were
considered significant.
Results
Patient Characteristics and Clinical Follow-up
The study population comprised 2950 patients (3583 lesions, 1.21 lesions per patient) who successfully completed the
study and had follow-up quantitative angiography. The overall angiographic restudy rate was 86% of all patients undergoing
successful PTCA. We found that 266 lesions in 249 patients out of 3583 lesions in 2950 patients complied with the
angiographic definition of total occlusion. Of these, 109 were absolute and 157 were functional total occlusions.
Tables 1 and 2 summarize the clinical and angiographic characteristics of the 249 patients with occlusions compared with
the 2701 with stenoses. Patients with total occlusions were younger and had a significantly higher rate of previous
myocardial infarction than patients with stenoses. Furthermore, the duration of angina in this group was significantly shorter
than in stenoses. Additionally, the presence of thrombus either before or after PTCA was significantly higher in occlusions.
Of the procedural characteristics, the nominal size of the largest balloon was significantly higher in stenoses, while the total
number of balloon inflations required, total duration, and maximum inflation pressure were higher in occlusions. Within the
occlusions group, there were no significant differences between lesions with total and functional occlusions.
Table 1. Baseline Clinical Characteristics of Patients With Occlusions and Stenoses Before Coronary Angioplasty
Lesion Type
Occlusion Stenoses
Patients, n 249 2701
Men, % 85.1 81.4
Age, y 54.4±9.6 57.4±9.3
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Lesion Type
Occlusion Stenoses
Smoking status, %
Ever smoked 73.1 75.5
Current smoker 17.2 18.3
Previous myocardial infarction, % 54.2 >41.1
Previous CABG, % 1.6 4.5
Previous PTCA, % 3.6 5.0
Diabetes mellitus, % 10.8 10.2
History of hypertension, % 30.1 30.5
History of hypercholesterolemia, % 33.3 31.5
History of peripheral vascular disease, % 3.6 5.1
CCS anginal class, %
None 6.0 5.6
I 10.0 11.2
II 33.7 32.4
III 28.9 30.2
IV 21.3 20.6
Duration of angina, wk 69±126 114±207
Medication at screening, %
Nitrates 57.6 66.2
Calcium antagonists 69.1 69.5
β-blockers 57.4 49.8
Anticoagulants 1.6 1.5
Aspirin 80.2 82.0
Laboratory investigations
Total cholesterol 5.58±1.30 5.85±1.23
Hemoglobin 8.89±0.80 8.86±0.83
Hematocrit 0.42 ±0.04 0.42±0.04
Platelet count 259±58 257 ±71
CABG indicates coronary artery bypass grafts; PTCA, percutaneous transluminal coronary angioplasty; and CCS,
Canadian Cardiovascular Society.
P<.05.
Table 2. Baseline Angiographic and Procedural Data of Patients With Occlusions and Stenoses Before Coronary
Angioplasty
Lesion Type
Occlusions Stenoses
Lesions, n 266 3317
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Lesion Type
Occlusions Stenoses
Lesions per patient, n 1.07 1.23
Number of diseased vessels, %
SVD 61.0 64.2
2-VD 34.5 27.5
3-VD 3.6 7.8
Lesion location, %
LAD 39.4 44.2
LCx 26.9 24.0
RCA 33.7 31.7
Type of lesion, %
Multiple irregularities 6.9 8.0
Side branch in lesion 21.1 20.2
Lesion calcification 12.0 12.4
PTCA procedure
Nominal size of largest balloon, mm 2.74±0.43 2.89±0.43
Balloon to artery ratio 1.14±0.18 1.13±0.19
Total number of inflations 4.6±3.2 3.47±2.2
Total duration of inflation, s 404±341 303±261
Maximum inflation pressure, atm 8.80±2.59 8.45±2.50
Post-PTCA result, %
Dissection at the dilated site 39.8 34.5
Thrombus visible (before or after PTCA) 12.9 >4.2
SVD indicates single-vessel disease; 2-VD, two-vessel disease; 3-VD, three-vessel disease; LAD, left anterior
descending; LCx, left circumflex artery; RCA, right coronary artery; and PTCA, percutaneous transluminal coronary
angioplasty.
P<.05.
Seventy-one (28.5%) of the patients with successfully dilated total occlusions and 598 (22.1%) of the patients with stenoses
had clinical end points (additional PTCA, coronary artery bypass graft [CABG] surgery, acute myocardial infarction, or
death) during follow-up. The difference was statistically significant (P=.026). The individual components of death,
myocardial infarction, CABG, and re-PTCA were 0%, 3.6%, 3.6%, and 21.3%, respectively, for occlusions and 0.2%, 2.8%,
2.4%, and 16.7%, respectively, for stenoses. The differences in the individual clinical end points between the two groups
were also statistically significant (P=.022). Fig 1 summarizes the time course of clinical end points. Although the mean time
to clinical follow-up was similar in the two groups, when we compared the pattern of occurrence of clinical end points by
way of the log-rank test, clinical end points in the occlusions group were found to occur earlier than in stenoses (P=.022).
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Figure 1. Graph showing cumulative distribution curves of clinical end points over time for total occlusions and
stenoses. Numbers given are mean±SD (days). *P<.05.
Interestingly, when lesions that went on to occlude at follow-up angiography were excluded from the analysis, 50 patients
(25.1%) with occlusions and 541 patients (21.1%) with stenoses reached a clinical end point, and the difference was no
longer statistically significant (P=.217). The individual clinical end points and the time to a clinical end point were also no
longer significantly different (P=.238 and .214, respectively).
Quantitative Angiographic Analysis
A mean of 2.12 matched angiographic projections per lesion had satisfactory quantitative analysis performed at the central
Angiographic Core Laboratory before and after PTCA and at follow-up (Table 3). The reference diameter was significantly
lower in occlusions than in stenoses, and this difference remained at follow-up. As expected, the MLD increased
substantially more after dilatation of occlusions than of stenoses, which was reflected in the substantially greater relative
gain. Nevertheless, the post-PTCA MLD was significantly lower in occlusions, perhaps reflecting the smaller vessel
diameter in this group (Fig 2a). When this was taken into account, the percent stenosis after PTCA was similar in both
groups (Fig 2b). At follow-up, previously occluded lesions deteriorated significantly more in terms of both absolute and
relative loss (Fig 3, Table 3), resulting in a smaller follow-up MLD and higher percent stenosis (Fig 2a and 2b, Table 3).
Thus, in addition to restenosis being higher when the continuous, absolute, and relative loss approach was used, the
restenosis rate when the categorical approach was used was also significantly higher (44.74% in occlusions compared with
33.95% in stenoses; P<.001; relative risk, 1.575; CI, 1.224 to 2.027).
Download figure | Download PowerPoint
Figure 2. Graphs showing (a) cumulative distribution curves of mean luminal diameter (MLD) after percutaneous
transluminal coronary angioplasty (PTCA) and at follow-up for total occlusions and stenoses and (b) cumulative
distribution curves of percentage stenosis after PTCA and at follow-up for total occlusions and stenoses. Numbers
given are mean±SD. *P<.001.
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Figure 3. Graphs showing (a) cumulative distribution curves of absolute loss (Abs) (change in mean luminal diameter
[MLD] from before percutaneous angioplasty to follow-up) for total occlusions and stenoses and (b) cumulative
distribution curves of relative (rel) loss (change in MLD from before percutaneous angioplasty to follow-up corrected
for vessel size) for total occlusions and stenoses. Numbers given are mean±SD. *P<.001.
Table 3. Quantitative Analyses of 266 Lesions in 249 Patients With Occlusions and 3317 Stenoses in 2701 Patients
Included in the Analysis
Lesion Type Significance Level
Occlusions, n=266 Stenoses, n=3317
Reference diameter, mm
Before angioplasty . . . 2.61 ±0.54 . . .
After angioplasty 2.46±0.49 2.67 ±0.51 <0.001
At follow-up 2.60±0.55 2.69 ±0.56 0.026
MLD, mm
Before angioplasty 0 1.08±0.29 . . .
After angioplasty 1.61±0.34 1.77±0.36 <0.001
At follow-up 1.18±0.69 1.46±0.57 <0.001
Differences in MLD, mm
Absolute gain 1.61±0.34 0.69 ±0.34 <0.001
Relative gain 0.66±0.09 0.27 ±0.13 <0.001
Absolute loss 0.43±0.68 0.31 ±0.51 <0.001
Relative loss 0.17±0.28 0.12 ±0.20 <0.001
Absolute net gain 1.18±0.69 0.38 ±0.53 <0.001
Net gain index 0.48±0.28 0.14 ±0.21 <0.001
Loss index 0.26±0.43 0.53 ±3.88 0.255
Percentage stenosis
Before angioplasty 100 57.83±9.86 . . .
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Lesion Type Significance Level
Occlusions, n=266 Stenoses, n=3317
After angioplasty 34.16±8.46 33.40±8.33 0.156
At follow-up 54.08±25.67 45.33±18.52 <0.001
DS at follow-up >50%, % 44.74 33.95 <0.001
MLD indicates minimal luminal diameter; DS, diameter stenosis.
Although angiographic restenosis was higher in occlusions than stenoses, there were no significant differences in the
presentation of restenosis between the two groups. Of recanalized total occlusions with angiographic restenosis, 40% were
symptom-free, while 18.5% complained of angina and 41.5% had a clinical end point. This compares with 39.9%, 18.7%,
and 41.4%, respectively, for stenoses with angiographic restenosis.
The higher restenosis rate in the occlusions was due predominantly to an increased number of occlusions at follow-up
angiography in this group (19.2% versus 5.0% for stenoses, P<.001). Thus, recanalized occlusions accounted for 23.5% of
all occlusions at follow-up angiography even though they formed only 7% of the total study population. The relative risk for
occlusion at follow-up angiography was 4.503 (95% CI, 3.196 to 6.344).
Subgroup Analysis of Occlusions Group
Subgroup analysis of the occlusions group revealed 109 absolute and 157 functional occlusions (Table 4). The reference
diameter after angioplasty was significantly higher in absolute than in functional occlusions, but this difference did not
persist to follow-up angiography. There were no significant differences in the MLD or percent stenosis after PTCA or at
follow-up (Table 4) between the two groups. The categorical restenosis rate (>50% diameter stenosis at follow-up) was
almost identical (44.95% versus 44.59%) in the two groups. Although the reocclusion rate in absolute occlusions tended to
be higher than in functional occlusions (23.9% versus 15.9%), this did not reach statistical significance (P=.06). By use of
the continuous measurements of restenosis, the absolute and relative loss tended to be lower in functional occlusions
(Table 4), resulting in a significantly higher net gain index and a significantly lower loss index.
Table 4. Quantitative Angiographic Analysis of 109 Total and 157 Functional Occlusions Included in the Analysis
Lesion Type Significance Level
TIMI 0, n=109 TIMI 1, n=157
Reference diameter, mm
Before angioplasty . . . . . . . . .
After angioplasty 2.55±0.52 2.40 ±0.56 0.015
At follow-up 2.66±0.55 2.56 ±0.54 0.200
MLD, mm
Before angioplasty . . . . . . . . .
After angioplasty 1.65±0.35 1.58±0.34 0.096
At follow-up 1.12±0.74 1.21±0.65 0.285
Differences in MLD, mm
Absolute gain 1.65±0.35 1.58±0.34 0.096
Relative gain 0.65±0.09 0.66±0.08 0.440
Absolute loss 0.53±0.69 0.36±0.67 0.051
Relative loss 0.21±0.28 0.15±0.28 0.063
Absolute net gain 1.12±0.74 1.21±0.65 0.285
Net gain index 0.44±0.29 0.51±0.28 0.037
Loss index 0.32±0.44 0.22±0.42 0.042
Percentage stenosis
Before angioplasty . . . . . . 0.285
After angioplasty 34.61±8.69 33.86±8.32 0.481
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Lesion Type Significance Level
TIMI 0, n=109 TIMI 1, n=157
At follow-up 57.52±26.38 51.70±24.96 0.072
DS at follow-up >50%, % 44.95 44.59 1.000
TIMI indicates Thrombosis in Myocardial Infarction classification; MLD, minimal luminal diameter.
Univariate and Multivariate Analyses of Restenosis in Total Occlusions
Univariate analysis of the available clinical-, procedural-, and lesion-related characteristics was performed to assess
whether any of these variables were associated with an increased categorical restenosis rate (Table 5). The only significant
associations were with a shorter duration of angina, a longer balloon total inflation time, higher residual stenosis after
PTCA, and a lower relative gain. Stepwise logistic regression analysis was used to further evaluate the relation between
this dichotomous definition of restenosis and the above variables, as well as all other clinical, lesion, and procedural
characteristics. The number of diseased vessels and the percent stenosis after PTCA were positively related; duration of
angina (in days) was negatively related to the probability of restenosis at follow-up (Table 6).
Table 5. Univariate Analysis of Patient-, Lesion-, and Procedure-Related Characteristics Relevant to Long-term
Restenosis  in 266 Occlusions
Restenosis at Follow-up, n=119 No Restenosis at Follow-up, n=147 Significance Level
CCS anginal class, % 0.790
None 6.7 4.8
I 8.4 11.6
II 31.1 34.7
III 31.1 29.3
IV 22.7 19.7
Duration of angina, wk 40±76 85 ±146 0.018
Medication at screening, n
Anticoagulants 1.7 1.4 1.000
Thrombocyte aggregation inhibitor 70.6 70.8 1.000
Aspirin 79.8 81.6 0.896
Persantin 14.3 9.2 0.400
Laboratory investigations
Hemoglobin 8.83±0.77 8.95 ±0.80 0.235
Hematocrit 0.42 ±0.04 0.42±0.04 0.398
Platelet count 261±63 257±56 0.564
Lesion location, % 0.554
LAD 37.0 43.5
LCx 27.7 24.5
RCA 35.3 32.0
Lesion characteristics, %
Concentric 19.3 15.6 0.645
Multiple irregularities 5.7 8.0 0.661
Branch point in stenosis 30.2 20.8 0.430
Coronary artery bend 9.4 7.2 0.707
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Restenosis at Follow-up, n=119 No Restenosis at Follow-up, n=147 Significance Level
Calcified lesion 14.3 10.2 0.408
Degree of collateral supply, % 0.704
No collaterals 52.3 47.1
Slight (minimal perfusion) 7.0 10.1
Medium (partial perfusion) 25.6 21.9
Major (complete perfusion) 12.8 16.8
Not assessed 2.3 4.2
PTCA procedure
Nominal size of largest balloon, mm 2.74 ±0.43 2.75±0.43 0.846
Balloon to artery ratio 1.13±0.18 1.15±0.19 0.293
Total number of inflations 4.6±3.4 4.6±3.0 0.925
Total duration of inflation, s 452±390 365±293 0.043
Maximum inflation pressure, atm 8.92±2.63 8.69±2.44 0.464
Post-PTCA result, %
Dissection at the dilated site 42.0 38.1 0.601
Thrombus visible (before or after PTCA) 15.1 9.5 0.227
Quantitative angiographic measurements
Reference diameter after PTCA 2.48±0.48 2.44±0.50 0.590
Minimal luminal diameter after PTCA 1.59±0.35 1.62±0.34 0.474
Stenosis after PTCA, % 35.50±7.99 33.08 ±8.70 0.019
Absolute gain 1.59±0.35 1.62 ±0.34 0.474
Relative gain 0.64±0.08 0.67 ±0.09 0.024
Lesion length after PTCA, mm 6.29 ±2.35 6.44±2.71 0.631
Time to follow-up, d 147 ±55 167±41 <0.001
CCS indicates Canadian Cardiovascular Society angina classification; LAD, left anterior descending; LCx, left circumflex;
RCA, right coronary artery; and PTCA, percutaneous transluminal coronary angioplasty. Values are mean±SD.
>50% diameter stenosis at follow-up angiography.
Retained in multivariate model.
Table 6. Regression Analyses to Evaluate the Respective Contributions of Clinical, Angiographic, and Procedural
Variables on the Categorical Restenosis Rate,  Absolute Loss, and Reocclusion During Follow-up
Variable Regression Coefficient Standard Error of Regression Coefficient P
Categorical restenosis rate
Duration of angina, d −0.0007 0.0003 .032
Diseased vessels, n 0.649 0.307 .034
Stenosis after PTCA, % 0.043 0.023 .049
Absolute loss
Total inflation time, s 0.0005 0.0001 .0004
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Variable Regression Coefficient Standard Error of Regression Coefficient P
Presence of thrombus 0.379 0.163 .021
Reocclusion at follow-up angiography
Total inflation time, s 0.002 0.0006 .002
Reference diameter after PTCA, mm −1.634 0.630 .009
PTCA indicates percutaneous transluminal coronary angioplasty. Logistic regression analysis was used for the
categorical restenosis rate and reocclusion at follow-up. Multiple linear regression analysis was used for absolute loss.
>50% diameter stenosis at follow-up.
Univariate analysis of clinical, procedural, and lesion characteristics related to absolute loss showed the only significant
associations to be with total inflation time (P=.0004), presence of thrombus (P=.0039), post-PTCA MLD (P=.0144), duration
of angina (P=.0262), left anterior descending coronary artery location (P=.0418), and lesion calcification (P=.0443). Multiple
linear regression analysis was used to further evaluate absolute loss. Of the variables assessed, total inflation time (in
seconds) and the presence of thrombus were both positively related to absolute loss (Table 6).
Univariate and Multivariate Analysis of Occlusions at Follow-up Angiography
The finding that the higher restenosis rate after dilatation of occlusions was due predominantly to an increased number of
reocclusions at follow-up angiography in this group prompted us to examine a number of variables predictive of reocclusion
(Table 7). The clinical characteristics of the two groups were similar, although lesions that went on to reocclude had a
shorter duration of angina (27±52 versus 74±132 weeks). Procedural characteristics were also similar, although lesions that
went on to reocclude required a longer balloon inflation (537±478 versus 373±294 seconds). Logistic regression analysis
was performed for the above and for all other clinical, angiographic, and procedural parameters thought to be associated
with the occlusion at follow-up. Of these variables, the total inflation time (in seconds) was positively related and the post-
PTCA reference diameter (in millimeters) was negatively related to reocclusion at follow-up angiography (Table 6).
Table 7. Univariate Analysis of Patient, Lesion, and Procedural Characteristics Relevant to Reocclusion During
Follow-up in 266 Occlusions
Reocclusion at Follow-up,
n=51
No Occlusion at Follow-up,
n=215
Significance Level, Univariate
Analysis
CCS anginal class, % 0.125
None 9.8 4.7
I 3.9 11.6
II 25.5 34.9
III 39.2 27.9
IV 21.6 20.9
Duration of angina, wk 27 ±52 74±132 0.044
Medication at screening, %
Anticoagulants 0 1.8 0.733
Thrombocyte aggregation inhibitor 64.7 72.1 0.384
Aspirin 73.5 82.4 0.344
Persantin 11.8 11.5 1.000
Laboratory investigations
Hemoglobin 8.82±0.81 8.91 ±0.78 0.505
Hematocrit 0.42 ±0.03 0.42±0.04 0.960
Platelet count 256±55 259±60 0.706
Lesion location, % 0.400
LAD 37.3 41.4
LCx 23.5 26.5
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Reocclusion at Follow-up,
n=51
No Occlusion at Follow-up,
n=215
Significance Level, Univariate
Analysis
RCA 39.2 32.1
Lesion characteristics, %
Concentric 16.3 20.7 0.653
Multiple irregularities 2.3 8.0 0.325
Branch point in stenosis 13.3 22.8 0.365
Coronary artery bend 9.3 8.0 1.000
Calcified lesion 15.7 11.2 0.514
Degree of collateral supply, % 0.779
No collaterals 44.7 50.3
Slight (minimal perfusion) 7.9 9.0
Medium (partial perfusion) 31.6 21.6
Major (complete perfusion) 13.2 15.6
Not assessed 2.6 3.6
PTCA procedure
Nominal size of largest balloon,
mm
2.67±0.47 2.76±0.42 0.214
Balloon to artery ratio 1.15±0.18 1.14±0.18 0.665
Total number of inflations 4.5±3.1 4.6±3.2 0.777
Total duration of inflation, s 537±478 373 ±294 0.003
Maximum inflation pressure, atm 9.10 ±2.80 8.72±2.46 0.370
Post-PTCA result, %
Dissection at the dilated site 43.1 39.1 0.708
Thrombus visible (before or after
PTCA)
19.6 10.2 0.107
Quantitative angiographic
measurements
Reference diameter after PTCA 2.36±0.47 2.48±0.49 0.105
Minimal luminal diameter after
PTCA
1.54±0.36 1.62±0.34 0.123
Stenosis after PTCA, % 34.52±8.33 34.08±8.51 0.735
Absolute gain 1.54±0.36 1.62±0.34 0.123
Relative gain 0.66±0.08 0.66±0.09 0.693
Lesion length after PTCA, mm 6.17±2.47 6.42±2.58 0.519
CCS indicates Canadian Cardiovascular Society; LAD, left anterior descending; LCx, left circumflex; RCA, right coronary
artery; and PTCA, percutaneous transluminal coronary artery. Values are mean±SD.
Retained in multivariate analysis.
Discussion
Our study specifically addressed the problem of long-term luminal renarrowing after dilatation of total coronary occlusions in
a large patient population with a control group, a high angiographic follow-up rate, and quantitative angiography at a
predetermined time interval. We demonstrated using both a categorical and a continuous approach that restenosis is
significantly greater after balloon dilatation of occlusions than of stenoses. Furthermore, we also showed that this is mainly
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the result of an increased rate of occlusion at follow-up angiography, which is specifically related to total inflation time and
reference diameter after intervention. We also demonstrated that restenosis and reocclusion occur to an equal extent in
both absolute and functional occlusions. These findings support and expand our current understanding of the long-term
angiographic outcome after successful angioplasty of coronary occlusions.
Our overall restenosis rate of 44.7% with the categorical (>50% diameter stenosis) approach compares with the previously
reported recurrence rate of 65% from our center  and is within the 20% to 65% range described previously.
Our restenosis rate, however, is significantly lower than those of the two largest studies published to date,  perhaps as a
result of our high angiographic follow-up rate. With univariate analysis, a number of risk factors have been postulated for the
higher restenosis rate after dilatation of chronic occlusions. These include anatomic factors such as lesion location (left
anterior descending and circumflex)  and absence of functional occlusion,  procedural factors such as multivessel
dilatations  and increased balloon inflations at higher pressures,  and residual stenosis after intervention.  A final risk
factor is thought to be the presence of collateral vessels, which may exert competitive pressure even after they are no
longer visibly functional  and thus lead to an increased restenosis rate.
Univariate analysis in our study confirmed significant associations between the categorical definition of restenosis (>50%
diameter stenosis at follow-up) and a shorter duration of angina, a longer balloon total inflation time, higher residual
stenosis after PTCA, and a greater relative gain. Multivariate analysis, however, suggested that the only significant positive
relations were with the number of diseased vessels and the percent stenosis after PTCA, while duration of angina was
negatively related to the probability of restenosis at follow-up. The positive relation between the number of diseased vessels
and the percent stenosis after PTCA with a categorical definition of restenosis is in keeping with previous studies in both
occlusions  and stenoses.  The negative relation with duration of angina is also in keeping with previous studies
suggesting a positive relation between recent onset of symptoms and a higher risk of restenosis.
Interestingly, when we looked at the absolute loss as a marker of restenosis, an outcome measure that may better indicate
the underlying pathological process involved, the above variables were no longer significant. The only significant relations
were found to be with total inflation time and the presence of thrombus. Both of these were positively related to the
subsequent absolute loss. The duration of balloon inflation as a positive risk factor may represent the sum total of the lesion
characteristics and a more difficult, more complex procedure with a consequently higher risk of occlusion, thereby markedly
influencing the absolute loss. In keeping with this is the fact that we also demonstrated total inflation time to be positively
related to the subsequent risk of occlusion at follow-up angiography. The positive relation between the presence of
thrombus and the subsequent absolute loss may also reflect a greater likelihood of subsequent occlusion, although we were
unable to demonstrate this in our study. Previous studies, however, showed thrombus to be a risk factor for subsequent
occlusion,  perhaps acting as a nidus for further platelet deposition.
The main reason for the significantly higher rate of angiographic restenosis in recanalized occlusions in our study was the
high rate of occlusion at follow-up angiography in this group (19.2% versus 5.0% after dilatation of stenoses). A number of
reasons may account for this. First, this group may represent a subset of the total population that has an intrinsic
hematological propensity to thrombosis. Although our laboratory data did not confirm this, there are other hematologic
factors such as fibrinogen levels that we did not measure that may influence reocclusion covertly.
Second, there are substantial morphological differences between lesions,  which may have considerable influence on the
subsequent risk of occlusion. Angiography provides little information on this or on the pathway of subsequent
recanalization, which may vary from subintimal to periatheromatous and transatheromatous.  What effect these variables
may have on the subsequent reocclusion and indeed restenosis rates is unknown. Differences in these lesion
characteristics may be reflected in the total inflation time, which was significantly higher in lesions more likely to reocclude.
Third, the coronary vasomotor responses after balloon angioplasty of chronic total occlusions may be abnormal. Distal
vasoconstriction occurs frequently after angioplasty and correlates well with coronary perfusion pressure, suggesting that
chronic hypoperfusion resets epicardial coronary autoregulation and that restoration of normal perfusion pressure after
PTCA may provoke reflex vasoconstriction,  thus precipitating early reocclusion.
Finally, the increased reocclusion rate may relate to local flow dynamics. The reference diameters before and after PTCA
and at follow-up were significantly lower in occlusions than in stenoses. Furthermore, within the occlusions group
multivariate analysis suggested that there is a negative relation between vessel size and subsequent risk of reocclusion.
Thus, successfully dilated occlusions in larger vessels were less likely to reocclude than those in smaller vessels. This is in
keeping with experimental work that suggested that smaller vessel diameters and hence higher shear rates favor local
platelet activation and deposition,  resulting in a greater likelihood of occlusion.
In addition to being responsible for the higher rate of angiographic restenosis, the high reocclusion rate in recanalized
occlusions also seems to have been responsible for the higher rate of clinical events in this group of patients. Patients with
recanalized occlusions had a significantly higher proportion of clinical events, mainly in terms of myocardial infarction,
CABG, and repeated PTCA. Furthermore, these occurred earlier in occlusions than in stenoses. When patients with
occlusions that went on to occlude at the time of follow-up angiography were removed from the analysis, the differences
between the two groups were no longer significant, suggesting that the excess risk relates to the higher rate of occlusion at
follow-up angiography. Interestingly, despite the higher rate of reocclusion in recanalized occlusions, there were no
significant differences in the presentation of restenosis between the two groups, with approximately 40% of patients with
angiographic restenosis in both groups being symptom-free.
Although studies of total occlusions suggest that there are important differences in the acute success rates between total
and functional occlusions,  our data suggest that in terms of restenosis and reocclusion, there is little difference between
the two groups. Although reocclusion after successful dilatation of total occlusions was higher than in functional occlusions
(23.9% versus 15.9%), this did not reach statistical significance. However, there was a tendency for functional occlusions to
mount less of a fibroproliferative response, which was reflected in the significantly greater net gain index and lower loss
index. The cause for this is unclear but is likely to reflect differences in the underlying pathological substrate.
Clinical Implications
Up to 20% of patients undergoing diagnostic catheterization have one or more total occlusions; thus, they make up 10% to
20% of the total angioplasty population.  Furthermore, in multivessel disease, they may make the difference in referring the
patient for angioplasty or for CABG surgery. Although great attention has been paid to increasing the acute success rate
with the use of sophisticated new devices such as the low-speed rotational angioplasty  and the Excimer laser,  relatively
little attention has been paid to long-term restenosis and its amelioration. Our results suggest that the higher restenosis in
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these lesions is likely to relate in part to the very high rate of occlusion at follow-up angiography in this group. Thus, it
suggests that if we can identify these lesions and stop reocclusion, then the angiographic and clinical courses of
recanalized total occlusions are likely to be similar to those of stenoses. The question of how we do this, however, is a
vexing one. The clinical course in our patient population and previous studies would suggest that reocclusions tend to occur
early.  A number of pharmacological and mechanical approaches have been tried. Ellis and colleagues  demonstrated
that drug therapy with aspirin, dipyridamole, or warfarin did not influence the overall restenosis rate. In a prospective study,
Di Sciascio and colleagues  demonstrated that restenosis is not modified by a longer balloon inflation time. A more recent
study assessed the value of coronary stenting for dissection with threatened closure following recanalization of total
occlusions.  The restenosis rate at follow-up was high at 57%, as was the recurrent occlusion rate (20%). When stenting
was used routinely after recanalization of chronic total occlusions and hence when vigorous anticoagulation was used, the
restenosis rate was low at 24% in a small patient population (65 patients) with an 80% angiographic follow-up rate.  Thus,
whether the reocclusion rate can be ameliorated by additional (eg, stenting) or alternative percutaneous revascularization
techniques (high-speed rotational atherectomy or laser angioplasty) with or without concomitant pharmacological therapy
remains to be established.
Study Limitations
A number of limitations of the present study are to be acknowledged. First, the study was a retrospective analysis of
prospectively gathered data and hence is subject to the limitations inherent in any retrospective study.
Second, there were minor variations in the entry criteria of the studies. In CARPORT and PARK, for example, patients were
randomized before PTCA, whereas in MERCATOR and MARCATOR, patients were entered into the trial only after a
successful angioplasty procedure.  Thus, we are unable to comment on clinical, angiographic, or procedural factors
influencing the acute success rate of the procedure. Furthermore, patients taking part in large multicenter studies like these
are selected in certain ways; therefore, care needs to be taken in extrapolating our results to the broader angioplasty
population.
Third, for obvious reasons, the reference diameter in the occlusions group before PTCA could not be reliably measured, so
we took the reference diameter after dilatation as the reference diameter before dilatation. The statistical analyses remain
valid, however, because even if we substitute the post-PTCA reference diameter for the pre-PTCA reference diameter in the
stenoses group, the significant differences between the two groups remain.
Fourth, because of the nature of the data, we unfortunately are unable to comment on whether certain previously
documented risk factors for restenosis such as the degree of collateral supply  or the measured coronary wedge
pressure  may relate to reocclusion rather than to long-term restenosis.
Finally, data from the active therapy group and the placebo group were amalgamated. Although the drugs did not seem to
influence the overall restenosis rate, the Ketanserin in the PARK study and the thromboxane A -receptor blocker in the
CARPORT studies may have had a covert influence on the reocclusion rate after dilatation of occlusions that we were
unable to detect.
Nonetheless, we believe that the merging of the data is justified because the data amalgamated were common to all studies
and the angiographic criteria were standardized, with one central laboratory performing the quantitative angiographic
analysis in all studies. Furthermore, the resulting large study population provides a unique opportunity to obtain accurate
quantitative angiographic data at a predetermined time interval in a field where such few data currently exist.
Conclusions
These results indicate that successfully dilated coronary occlusions, both total and functional, have a higher rate of
angiographic restenosis at 6 months than stenoses. This is due chiefly to a higher rate of occlusion at follow-up
angiography in this group of lesions. Measures aimed at reducing restenosis after successful dilatation of coronary
occlusions should therefore be focused in this direction.
Presented in part at the 66th Scientific Sessions of the American Heart Association, Atlanta, Ga, November 8-11, 1993.
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